WO2006015283A3 - Treatment of benign prostatic hyperplasia - Google Patents
Treatment of benign prostatic hyperplasia Download PDFInfo
- Publication number
- WO2006015283A3 WO2006015283A3 PCT/US2005/027133 US2005027133W WO2006015283A3 WO 2006015283 A3 WO2006015283 A3 WO 2006015283A3 US 2005027133 W US2005027133 W US 2005027133W WO 2006015283 A3 WO2006015283 A3 WO 2006015283A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- treatment
- benign prostatic
- prostatic hyperplasia
- lonidamine
- prophylaxis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007523870A JP2008508316A (en) | 2004-07-29 | 2005-07-29 | Treatment of benign prostatic hyperplasia |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US59283304P | 2004-07-29 | 2004-07-29 | |
US60/592,833 | 2004-07-29 | ||
US66106705P | 2005-03-11 | 2005-03-11 | |
US60/661,067 | 2005-03-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006015283A2 WO2006015283A2 (en) | 2006-02-09 |
WO2006015283A3 true WO2006015283A3 (en) | 2006-06-22 |
Family
ID=35787884
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/027133 WO2006015283A2 (en) | 2004-07-29 | 2005-07-29 | Treatment of benign prostatic hyperplasia |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP2008508316A (en) |
WO (1) | WO2006015283A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7898642B2 (en) | 2004-04-14 | 2011-03-01 | Asml Netherlands B.V. | Lithographic apparatus and device manufacturing method |
WO2017123826A1 (en) | 2016-01-14 | 2017-07-20 | Beth Israel Deaconess Medical Center, Inc. | Mast-cell modulators and uses thereof |
EP3564214B1 (en) | 2018-05-04 | 2024-07-03 | Universita' Degli Studi G. D'annunzio Chieti - Pescara | Indazole derivatives as modulators of the cannabinoid system |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5458597A (en) * | 1993-11-08 | 1995-10-17 | Zomed International | Device for treating cancer and non-malignant tumors and methods |
-
2005
- 2005-07-29 JP JP2007523870A patent/JP2008508316A/en not_active Withdrawn
- 2005-07-29 WO PCT/US2005/027133 patent/WO2006015283A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5458597A (en) * | 1993-11-08 | 1995-10-17 | Zomed International | Device for treating cancer and non-malignant tumors and methods |
Also Published As
Publication number | Publication date |
---|---|
JP2008508316A (en) | 2008-03-21 |
WO2006015283A2 (en) | 2006-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004064735A3 (en) | Treatment of benign prostatic hyperplasia | |
EA200401043A1 (en) | Treatment of benign prostatic hyperplasia by the selective modulator of the androgen receptor (sarm) | |
MX2020008616A (en) | Sublingual fentanyl spray. | |
MXPA05001298A (en) | Compounds with the bicyclo[4.2.1]nonane system for the treatment of flaviviridae. | |
EP1485381B8 (en) | Azolylaminoazine as inhibitors of protein kinases | |
ECSP034922A (en) | PIRROLOPIRIMIDINES | |
WO2006121861A3 (en) | Biphenylazetidinone cholesterol absorption inhibitors | |
MXPA04005790A (en) | Compounds and uses thereof for decreasing activity of hormone-sensitive lipase. | |
IN2005KO00312A (en) | ||
PT1509232E (en) | A combination of an nmda-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer`s disease | |
AU2003218215A1 (en) | Azolylaminoazines as inhibitors of protein kinases | |
AU2003220300A1 (en) | Compositions useful as inhibitors of protein kinases | |
WO2007025005A3 (en) | Sustained release formulations of nalbuphine | |
NO20082088L (en) | Acetidines as MEK inhibitors for the treatment of proliferative diseases | |
NO20100093L (en) | Peptidomimetic protease inhibitors | |
NO20061625L (en) | Treatment and / or prevention of urinary incontinence using prodrugs of gaba analogues | |
HUP0202570A1 (en) | Compositions and therapeutic methods involving isoflavones and analogues thereof | |
IL179206A0 (en) | Pyrrolylpyrimidine derivatives and pharmaceutical compositions containing the same | |
NO20056218L (en) | Substituted pyrrole derivatives and their use as HMF-CoA reductase inhibitors | |
GB0222514D0 (en) | Organic compounds | |
WO2006104870A3 (en) | Methods of treating benign prostatic hyperplasia or lower urinary track symptoms by using pde 5 inhibitors | |
AU2002248319A1 (en) | Pharmaceutical composition for the prevention and treatment of scar tissue | |
WO2004043456A8 (en) | Cholesterol absorption inhibitors for the treatment of demyelination | |
HUP0501111A2 (en) | Treatment of severe pneumonia by administration of tissue factor pathway inhibitor | |
AU2003295336A1 (en) | Use of etodoclac to treat hyperplasia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2007523870 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |